Remunity

Image of the Remunity subcutaneous pump
Image of the Remunity subcutaneous pump
Remodulin SC pump can clip on your belt or fit in your pocket. The small wireless remote can also fit in your pocket or stow in a purse
Remunity has a small, discreet, wireless remote

Coming soon: Remunity Pump for Remodulin

NEW

A small, simple subcutaneous pump for patients starting or on a stable dose of Remodulin

Small

Remunity is only 2" in diameter, 3/4" thick, and weighs only 1.7 ounces, making it smaller than most smartphones. It easily fits on your belt or in your pocket, and can be programmed using a separate, small remote.

Simple

Prefilled Remodulin cassettes are delivered to you by your Specialty Pharmacy. You can easily connect the cassette to your pump without the need for manual cassette filling or syringes. Each cassette can keep you going for up to 3 days (72 hours).

Safe

Remunity also has a water-resistant casing* so your pump can truly go with you wherever you go.

*The pump can tolerate immersion to depths of up to 8 ft for 30 min and 12 ft for up to 3 min.

Informative video about the benefits of REMUNITY

Remunity Announcement

Learn more about the latest pump offering for Remodulin.

REMUNITY AVAILABILITY

Update on Remunity Availability, February 2020

United Therapeutics and DEKA Research & Development Corp. proudly announce the clearance of the Remunity Pump for Remodulin by the US Food and Drug Administration (FDA). Launch preparations are underway with the anticipated timeline of later this year.

Remunity is a discreet, subcutaneous delivery system designed for adults (age 22 years and greater) with pulmonary arterial hypertension (PAH). The cassettes, which contain enough drug for up to 3 days (72 hours), arrive from the Specialty Pharmacy prefilled, eliminating the need for the patient to mix or fill. Remunity is small, water resistant, and programmed using a wireless remote making it safe and simple to use.

Remunity is the latest advancement from United Therapeutics to improve treatment options for PAH patients.

More information about United Therapeutics, DEKA, and Remunity may be found here.

For Important Safety Information on Remunity, please click here.

Remodulin® (treprostinil) Injection

Important Safety Information for Remodulin

Before you take Remodulin, tell your healthcare provider if you:

What are the serious side effects of Remodulin?

What are the possible side effects of Remodulin?

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive.

What is Remodulin?

Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.

In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

REMISIconOct19

To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

PAH=pulmonary arterial hypertension; WHO=World Health Organization.

Remodulin® (treprostinil) Injection

Important Safety Information for Remodulin

Before you take Remodulin, tell your healthcare provider if you:

What are the serious side effects of Remodulin?

What are the possible side effects of Remodulin?

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive.

What is Remodulin?

Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.

In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

REMISIconOct19

To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

PAH=pulmonary arterial hypertension; WHO=World Health Organization.